ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

U.S. Cigarette Sales Dropped 4.2 Percent Last Year

March 31, 2006

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

April 26, 1996

In Brief: Judith Salerno Named President and CEO of Komen

June 21, 2013

Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival

August 30, 2013

ACS Plans 7 Hearings Around U.S. On cancer In The Disadvantaged

April 7, 1989

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013